Indications for botulinum toxin in internal medicine;Botulinumtoxin: Internistische indikationen

Internist

Volumn 43, Issue 12, 2002, Pages 1566-1574

  Allescher, Hans Dieter ^a   Storr, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

AMYOTROPHIC LATERAL SCLEROSIS; DYSTONIA; ESOPHAGUS ACHALASIA; ESOPHAGUS SPASM; GASTROINTESTINAL DISEASE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; INTERNAL MEDICINE; MIGRAINE; MULTIPLE SCLEROSIS; REVIEW; SPASTICITY; TREATMENT INDICATION; TREMOR; URINARY TRACT DISEASE;

ADULT; BOTULINUM TOXINS; CHILD; DYSTONIA; ESOPHAGEAL ACHALASIA; GASTROINTESTINAL DISEASES; HUMANS; MUSCLE SPASTICITY; SPASM; TREATMENT OUTCOME;

EID: 0036932307     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-002-0754-y     Document Type: Review

References (78)

1. Klein AW (2001) Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg 20: 109-120
2. Dressler D, Munchau A, Bhatia KP, Quinn NP, Bigalke H (2002) Antibody-induced botulinum toxin therapy failure: Can it be overcome by increased botulinum toxin doses? Eur Neurol 47: 118-121
3. Dressler D, Bigalke H (2002) Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy. Mov Disord 17: 170-173
4. Dressler D (2000) Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol 247: 809-810
5. Malnick SD, Metchnik L, Somin M, Bergman N, Attali M (2000) Fatal heart block following treatment with botulinum toxin for achalasia. Am J Gastroenterol 95: 3333-3334
6. Khurana V, Nehme O, Khurana R, Barkin JS (2001) Urinary retention secondary to detrusor muscle hypofunction after botulinum toxin injection for achalasia. Am J Gastroenterol 96: 3211-3212
7. Pasricha PJ, Ravich WJ, Kalloo AN (1993) Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 105: 1045-1049
8. Pasricha PJ, Ravich WJ, Kalloo AN (1993) Botulinum toxin for achalasia. Lancet 341: 244-245
9. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN (1995) Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332: 774-778
10. Fishman VM, Parkman HP, Schiano TD et al. (1996) Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 91: 1724-1730
11. Ferrari AP, Siqueira ES, Brant CQ (1995) Treatment of achalasia in Chagas' disease with botulinum toxin. N Engl J Med 332: 824-825
12. Eaker JM, Gordon EY (1996) Esophageal botulinum toxin injection in high risc achalasia patients: A prospective trial. Gastroenterology 110: A991
13. Annese V, Basciani M, Lombardi G, Caruso N, Perri F, Simone P, Andriulli A (1996) Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation. Gastrointest Endosc 44: 461-465
14. Muehldorfer SM, Schneider TH, Hochberger J, Martus P, Hahn EG, Ell C (1999) Esophageal achalasia: Intrasphincteric injection of botulinum toxin A versus balloon dilatation. Endoscopy 31: 517-521
15. Imperiale TF, O'Connor JB, Vaezi MF, Richter JE (2000) A cost-minimization analysis of alternative treatment strategies for achalasia. Am J Gastroenterol 95: 2737-2745
16. Annese V, Basciani M, Perri F et al. (1996) Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 111: 1418-1424
17. Allescher HD, Storr M, Seige M et al. (2001) Treatment of achalasia: Botulinum toxin injection versus pneumatic balloon diolatation - A prospective study with a long-term follow-up. Endoscopy 33: 1007-1017
18. Neubrand M, Scheurlen C, Schepke M, Sauerbruch T (2002) Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 34: 519-523
19. West RL, Hirsch DP, Bartelsman JF, de Borst J, Ferwerda G, Tytgat GN, Boeckxstaens GE (2002) Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol 97: 1346-1351
20. Storr M, Born, P, Frimberger E et al. (2002) Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment. Biomed Chromatogr Gastroenterol 2: 19
21. Wehrmann T, Kokabpick H, Jacobi V, Seifert H, Lembcke B, Caspary WF (1999) Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum. Endoscopy 31: 352-358
22. Annese V, D'Onofrio V, Andriulli A (1998) Botulinum toxin in long-term therapy for achalasia. Ann Intern Med 128: 696,
23. D'Onofrio V, Miletto P, Leandro G, Iaquinto G (2002) Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 34: 105-110
24. Zarate N, Mearin F, Baldovino F, Armengol JR, Malagelada JR (2002) Achalasia treatment in the elderly: Is botulinum toxin injection the best option? Eur J Gastroenterol Hepatol 14: 285-290
25. ImperialeTF, O'Connor JB, Vaezi MF, Richter JE (2000) A cost-minimization analysis of alternative treatment strategies for achalasia. Am J Gastroenterol 95: 2737-2745
26. Mahle CD, Goggins GD, Agarwal P, Ryan E, Watson AJ (1997) Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 12: 690-696
27. Panaccione R, Gregor JC, Reynolds RP, Preiksaitis HG (1999) Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: A cost minimization analysis. Gastrointest Endosc 50: 492-498
28. Wehrmann T, Schmitt T, Dietrich CF, Caspary WF, Seifert H (2000) Manometrically-guided endoscopic injection of botulinum toxin for esophageal achalasia: A pilot trial. Z Gastroenterol 38: 899-903
29. Brant CQ, Nakao F, Ardengh JC, Nasi A, Ferrari AP (1999) Echoendoscopic evaluation of botulinum toxin intrasphincteric injections in Chagas'disease achalasia. Dis Esophagus 12: 37-40
30. Sampaio C, Ferreira JJ, Simoes F et al. (1997) DYSBOT: A single blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin A. Mov Disord 12: 1013-1018
31. Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M (2002) Respective potencies of Botox and Dysport: A double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72: 459-462
32. Poewe W (2002) Respective potencies of Botox and Dysport: A double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72: 430
33. Annese V, Bassotti G, Coccia G et al. (2000) A multicenter randomised study of intrasphincteric botulinum toxin in patients with esophageal achalasia. GISMAD Achalasia Study Group. Gut 46: 597-600
34. Malnick SD, Metchnik L, Somin M, Bergman N, Attali M (2000) Fatal heart block following treatment with botulinum toxin for achalasia. Am J Gastroenterol 95: 3333-3334
35. Bonavina L, Incarbone R, Antoniazzi L, Reitano M, Peracchia A (1999) Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for esophageal achalasia. Ital J Gastroenterol Hepatol 31: 827-830
36. Bonavina L, Incarbone R, Reitano M, Antoniazzi L, Peracchia A (2000) Does previous endoscopic treatment affect the outcome of laparoscopic Heller myotomy? Ann Chir 125: 45-49
37. Ip KS, Cameron DJ, Catto-Smith AG, Hardikar W (2000) Botulinum toxin for achalasia in children. J Gastroenterol Hepatol 15: 1100-1104
38. Hurwitz M, Bahar RJ, Ament ME et al. (2000) Evaluation of the use of botulinum toxin in children with achalasia. J Pediatr Gastroenterol Nutr 30: 509-514
39. Miller LS, Parkman HP, Schiano TD et al. (1996) Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 41: 2025-2031
40. Nebendahl JC, Brand B, von Schrenck T et al. (1999) Treatment of diffuse esophageal spasm with botulinum toxin: A prospective study with 6 month follow up. Gastroenterology 116: A-802
41. Storr M, Allescher HD, Rösch T, Born P, Weigert N, Classen M (2001) Treatment of symptomatic diffuse esophageal spasm by injection of Botulinum toxin: A prospective study and long term follow up. Gastrointest Endosc 54: 754-759
42. Storr M, Allescher HD, Rösch T, Born P, Weigert N, Classen M (2000) Botulinum Toxin (BTX) Injektionen in der Behandlung des symptomatischen diffusen Ösophagusspasmus. Endoskopie heute 13: 47
43. Miller LS, Pullela SV, Parkman HP, Schiano TD, Cassidy MJ, Cohen S, Fisher RS (2002) Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal. Am J Gastroenterol 97: 1640-1646
44. Lacy BE, Zayat EN, Crowell MD, Schuster MM (2002) Botulinum toxin for the treatment of gastroparesis: A preliminary report. Am J Gastroenterol 97: 1548-1552
45. Blitzer A, Brin MF (1997) Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 116: 328-330
46. Brant CQ, Siqueira ES, Ferrari AP (1999) Botulinum toxin for oropharyngeal dysphagia: Case report of flexible endoscope-guided injection. Dis Esophagus 12: 68-73
47. Alberty J, Oelerich M, Ludwig K, Hartmann S, Stoll W (2000) Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope 110: 1151-1156
48. Gui D, De Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A (2000) Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment Pharmacol Ther 14: 829-834
49. Heinen F, Mall V, Ruckauer KD, Greiner P, Sontheimer J, Brandis M, Korinthenberg R (1999) Lack of response to botulinum toxin A in patients with hypertrophic pyloric stenosis. Eur J Pediatr 158: 436
50. Wiesel PH, Schneider R, Dorta G, Blum AL, Gillet M, Michetti P (1997) Botulinum toxin for refractory postoperative pyloric spasm. Endoscopy 29: 132
51. Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS (2002) Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 55: 920-923
52. Miller LS, Szych GA, Kantor SB et al. (2002) Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 97: 1653-1660
53. Lacy BE, Zayat EN, Crowell MD (2002) Case report: Botulinum toxin in hypertensive lower esophageal sphincter: A manometric case study. Dysphagia 17: 75-80
54. Pasricha PJ, Miskovsky EP, Kalloo AN (1994) Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 35: 1319-1321
55. Muehldorfer SM, Hahn EG, Ell C (1997) Botulinum toxin injections as a diagnostic tool for verification of sphincter of oddi dyskinesia causing recurrent pancreatitis. Endoscopy 29: 120-124
56. Wehrmann T, Seifert H, Seipp M, Lembcke B, Caspary WF (1998) Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 30: 702-707
57. Wehrmann T, Schmitt TH, Arndt A, Lembcke B, Caspary, WF, Seifert H (2000) Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction. Aliment Pharmacol Ther 14: 1469-1477
58. Wehrmann T, Schmitt T, Seifert H (1999) Endoscopic botulinum toxin injection into the minor papilla for treatment of idiopathic recurrent pancreatitis in patients with pancreas divisum. Gastrointest Endosc 50: 545-548
59. Maria G, Sganga G, Civello IM, Brisinda G (2002) Botulinum neurotoxin and other treatments for fissure-in-ano and pelvic floor disorders. Br J Surg 89: 950-961
60. Jost WH, Schimrigk K (1994) Therapy of anal fissure using botulinum toxin. Dis Colon Rectum 37: 1321-1324
61. Jost WH (1997) 100 Cases of anal fissure treated with botulinum toxin. Dis Colon Rectum 40: 1029-1032
62. Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (2000) Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg 179: 46-50
63. Fernandez Lopez F, Conde Freire R, Rios Rios A, Garcia Iglesias J, Cainzos Fernandez M, Pontel Lesquereux J (1999) Botulinum toxin for the treatment of anal fissure. Dig Surg 16: 515-518
64. Minguez M, Herreros B, Espi A, Garcia-Granero E, Sanchiz V, Mora F, Lledo S, Benages A (2002) Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology 123: 112-117
65. Jost WH, Schrank B (1999) Repeat botulin toxin injections in anal fissure: In patients with relapse and after insufficient effect of first treatment. Dig Dis Sci 44: 1588-1589
66. Lysy J, Israelit-Yatzkan Y, Sestiery-Ittah M, Weksler-Zangen S, Goldin E (2001) Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure. Gut 48: 221-224
67. Madalinski MH, Slawek J, Zbytek B, Duzynski W, Adrich Z, Jagiello K, Kryszewski A (2001) Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure. Hepatogastroenterology 48: 977-979
68. Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (1999) A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 341: 65-69
69. Ron Y, Avni Y, Lukovetski A, Wardi J, Geva D, Birkenfeld S, Halpern Z (2001) Botulinum toxin type-A in therapy of patients with anismus. Dis Colon Rectum 44: 1821-1826
70. Joo JS, Agachan F, Wolff B, Nogueras JJ, Wexner SD (1996) Initial North American experience with botulinum toxin type A for treatment of anismus. Dis Colon Rectum 39: 1107-1111
71. Hallan RI, Williams NS, Melling J, Waldron DJ, Womack NR, Morrison JF (1988) Treatment of anismus in intractable constipation with botulinum A toxin. Lancet 2: 714-717
72. Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Albanese A (2000) Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis Colon Rectum 43: 376-380
73. Shafik A, El Sibai O (1998) Botulin toxin in the treatment of nonrelaxing puborectalis syndrome. Dig Surg 15: 347-351
74. Albanese A, Maria G, Bentivoglio AR, Brisinda G, Cassetta E, Tonali P (1997) Severe constipation in Parkinson's disease relieved by botulinum toxin. Mov Disord 12: 764-766
75. Maria G, Brisinda G, Bentivoglio AR, Albanese A, Sganga G, Castagneto M (2001) Anterior rectocele due to obstructed defecation relieved by botulinum toxin. Surgery 129: 524-529
76. Christiansen J, Bruun E, Skjoldbye B, Hagen K (2001) Chronic idiopathic anal pain: Analysis of ultrasonography, pathology, and treatment. Dis Colon Rectum 44: 661-665
77. Langer JC, Birnbaum E (1997) Prelimminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease. J Pediatr Surg 32: 1059-1061
78. Minkes RK, Langer JC (2000) A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease. J Pediatr Surg 35: 1733-1736